Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Salvage Therapy × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Observational 1 Interventional 1

Sponsor

Cancer Type

Dermatologic 1 CNS 1

Conditions

Melanoma 1 Brain Neoplasms 1

Interventions

pembrolizumab 539 Specimen Handling 506 Magnetic Resonance Spectroscopy 436 Carboplatin 351 Cyclophosphamide 333 Biopsy 304 Cisplatin 295 Paclitaxel 265 Nivolumab 250 Gemcitabine 227 Radiotherapy 222 Bevacizumab 192 Dexamethasone 190 fludarabine 183 venetoclax 178 Oxaliplatin 158 Docetaxel 156 Fluorouracil 154 atezolizumab 152 durvalumab 151 Rituximab 148 Capecitabine 143 Pemetrexed 142 Doxorubicin 134 Radiation 130 Lenalidomide 128 Prednisone 124 Standard of Care 121 Radiosurgery 118 Drug Therapy 117

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03340129 2026-02-02

ABC-X

Melanoma Institute Australia

Phase 2 Recruiting

CNSDermatologic

Brain Neoplasms, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡